Phase II trial of concomitant low-dose temozolomide with radiation therapy (RT) followed by 12 months of temozolomide and irinotecan for newly diagnosed glioblastoma (GBM): Updated results of RTOG 04-20 Conference

Lieberman, Frank, Moughan, Jennifer, Tsein, Christina et al. (2007). Phase II trial of concomitant low-dose temozolomide with radiation therapy (RT) followed by 12 months of temozolomide and irinotecan for newly diagnosed glioblastoma (GBM): Updated results of RTOG 04-20 . NEURO-ONCOLOGY, 9(4), 528-528.

International Collaboration

cited authors

  • Lieberman, Frank; Moughan, Jennifer; Tsein, Christina; Curran, Walter; Werner-Wasik, Maria; Smith, Ryan; Grossheim, Linda; Hug, Eugen; Robins, Ian; Mehta, Minesh

authors

date/time interval

  • November 15, 2007 -

publication date

  • October 1, 2007

webpage

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • Dallas, TX

Conference

  • 12th Annual Meeting of the Society-for-Neuro-Oncology

publisher

  • DUKE UNIV PRESS

start page

  • 528

end page

  • 528

volume

  • 9

issue

  • 4